peptide-stability

Details up front: a GLP-1 receptor agonist · minus 80 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What…

Details up front: mazdutide · sixteen weeks · minus 20 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a…

Numbers first: racemisation · dulaglutide · 40 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…

What I have: mazdutide · room temperature. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…

What I have: a GLP-1 receptor agonist · sixteen weeks · 30 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone…

What I have: mazdutide · 25 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…

The specifics, since they change the answer: liraglutide · 25 °C. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this…

The particulars: deamidation · survodutide · 4 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…

Details up front: a GLP-1 receptor agonist · 4 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this…

The specifics, since they change the answer: fibrillation · survodutide · minus 20 °C. I understand the observation; what I do not understand is the mechanism behind…

What I have: cagrilintide · 10 mg/mL · eight weeks. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial;…

The particulars: liraglutide · minus 20 °C. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…

The case in front of me: survodutide · 20 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision…

Setup, so nobody has to ask: aggregation · minus 20 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…

For reference: liraglutide · 2.5 mg/mL · twelve weeks. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested…

The case in front of me: ecnoglutide · 2–8 °C. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one.…

Concretely: 37 °C · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Is there data…

Setup, so nobody has to ask: aggregation · cagrilintide · room temperature. The empirical answer seems settled. The explanation does not. If the honest answer is that…

What I am working with: dulaglutide · 4 °C. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I…

Setup, so nobody has to ask: aggregation · minus 80 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…

Setup, so nobody has to ask: aggregation · a GLP-1 receptor agonist · 4 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts…

What I am working with: retatrutide · two weeks · minus 20 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have…

For reference: fibrillation · semaglutide · 2–8 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review…

Numbers first: a GLP-1 receptor agonist · 2.5 mg/mL. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has…